Article Text
Statistics from Altmetric.com
Symposium
S1
Symposium 1: April 27 (Thu), 8:00–12:00
Opioids and Cancer Pain: Evolving Science and Practice
S1-1
Opioid Receptors: Structure, Function and Plasticity
Christoph Stein (Charité–Universitätsmedizin Berlin, Germany)
S1-2
Genetic variation and the balance between opioid benefits and risk
Pål Klepstad (Norwegian University of Science and Technology, Norway)
S1-3
Three Examples of Science Translation to Practice: Opioid Rotation, Management of Breakthrough Pain, Role of Methadone
Eduardo Bruera (University of Texas MD Anderson Cancer Center, USA)
S1-4 Keynote lecture
‘Balance at the Bedside’—Optimizing Benefits and Minimizing Risk Through Best Practices
Russell Portenoy (MJHS Institute for Innovation in Palliative Care, USA)
S2
Symposium 2: April 28 (Fri), 8:00–12:00
Making the Case for Integration of Spiritual Issues in Palliative Care
S2-1 Keynote lecture
Developing Educational and Clinical Models in Interprofessional Spiritual Care: An Essential Component of Palliative Care
Christina Puchalski (George Washington University, USA)
S2-2
Supporting the Integration of Spiritual Care as an Essential Component of Palliative Care
Vanessa Battista (Dana-Farber Cancer Institute, USA)
S2-3
Spirituality and Palliative Care: Current Evidence and Future Priorities?
Karen Steinhauser (Duke University School of Medicine/Durham Veterans Affairs Medical Center, USA)
S2-4
Palliative care through the lens of specialist spiritual care
Anne Vandenhoeck (Katholieke Universiteit Leuven, Belgium)
S2-5
Embracing a spiritual and compassionate care for patients living with advanced and terminal illnesses with Existential and Spiritual Distress
Marvin Omar Delgado Guay (University of Texas MD Anderson Cancer Center, USA)
S3
Symposium3: April 29 (Sat), 13:00–17:00
Euthanasia, Physician Assisted Suicide and Their Connection to Palliative Care
S3-1
The ethical, legal and professional landscape of physician hastened death
Richard Huxtable (University of Bristol, UK)
S3-2
Missing Goldilocks and Killing Kant: The Price of Canada’s Headlong Assisted Death Expansion
K. Sonu Gaind (University of Toronto, Canada)
S3-3
When is medically assisted dying appropriate?
Madeline Li (Princess Margaret Cancer Centre, Canada)
S3-4
Euthanasia and Assisted Suicide: ‘What’s Dignity Got to Do with It?’
Harvey Max Chochinov (University of Manitoba, Canada)
Plenary Session
P1
Plenary Session1: April 27 (Thu), 13:00–17:00
Recent Progress in the Integration of Standard Oncology and Palliative Care
P1-1
Integrating oncology and palliative care to improve patient care: Providing the right intervention, at the right time for the right patient
David Hui (University of Texas MD Anderson Cancer Center, USA)
P1-2
Integrating palliative care aside curative treatment in hemato-oncological disease
Thomas William LeBlanc (Duke University School of Medicine, USA)
P1-3
Immune-related adverse events associated with immunotherapeutic agents
Aung Naing (University of Texas MD Anderson Cancer Center, USA)
P1-4
Cancer rehabilitation in palliative care
Jack Fu (University of Texas MD Anderson Cancer Center, USA)
P2
Plenary Session2: April 28 (Fri), 13:00–17:00
Determinants and Effects of Existential Suffering in the Clinics of Palliative Care
P2-1
The role of liaison psychiatry for existential questions in palliative care
Friedrich Stiefel (Lausanne University Hospital, Switzerland)
P2-2
Communicating with patients experiencing existential threat
Peter Salmon (University of Liverpool, UK)
P2-3
How existentially distressed patients affect clinicians
Sarah Dauchy (AP-HP. Centre–University of Paris, French)
P2-4
Discourses on death and dying and their effects on palliative care
Camilla Zimmermann (University of Toronto, Canada)
P3
Plenary Session3: April 29 (Sat), 7:05–12:00
Technology-Enabled Care (TEC) in Palliative Care
P3-1
Medical digital transformation after COVID-19: Industry 4.0 and healthcare
Fumiaki Ikeno (Stanford University, USA)
P3-2
Intelligence augmentation in healthcare platform—Microsoft’s view
Keren Priyadarshini (Microsoft Asia, Singapore)
P3-3
Telemedicine, artificial intelligence, and digital therapeutics: Rise of the Robots or the future of compassionate care?
Mihir M. Kamdar (Massachusetts General Hospital, USA)
P3-4
Institutional implementation of electronic patient reported outcome measures and palliative care telemedicine during the COVID pandemic at the National Cancer Institute of Milan
Augusto Caraceni (University of Milan/Fondazione IRCCS Istituto Nazionale dei Tumori, Italy)
P3-5
The ethical dimensions of technology-enabled palliative care
Ralf J. Jox (Lausanne University Hospital, Switzerland)
P3-Additional Remarks
Randomized Trial of a Novel Artificial Intelligence/Machine Learning Model to Predict the Need for Specialty Palliative Care in Hospitalized Patients
Jacob Strand (Mayo Clinic, USA)
Luncheon/Evening Seminar
L1
Luncheon Seminar1: April 27 (Thu), 12:00–13:00
Integration of Oncology and Palliative Care: A review of its history and directions for the future
Stein Kaasa (University of Oslo/Oslo University Hospital/Director of the European Palliative Care Research Center, Norway)
L2
Luncheon Seminar2: April 28 (Fri), 12:00–13:00
Palliative Care in Medicine and in Life: An Existential Account
Sheldon Solomon (Skidmore College, USA)
L3
Luncheon Seminar3: April 29 (Sat), 12:00–13:00
Supportive oncology: A novel department in a major US cancer institute
Declan Walsh (Levine Cancer Institute/Editor-in-chief of BMJ Supportive and Palliative Care, USA)
E1
Evening Seminar1: April 27 (Thu), 17:00–18:00
Palliative nursing—an essential component for the future of palliative care
Philip Larkin (Lausanne University Hospital, Switzerland)
E2
Evening Seminar2: April 28 (Fri), 17:00–18:00
Global palliative care development: Promoting access to services and essential medicines, through understanding of international policy and processes
Joseph Clark (Wolfson Palliative Care Research Centre, University of Hull, UK)
Poster Session
April 27 (Thu), 12:00–18:00
April 28 (Fri), 8:00–18:00
April 29 (Sat), 8:00–15:00